More about

Janus Kinase Inhibitor

News
August 22, 2023
2 min read
Save

Colectomies ‘infrequent’ in patients with moderate to severe UC receiving tofacitinib

Colectomies ‘infrequent’ in patients with moderate to severe UC receiving tofacitinib

All patients with moderate to severe ulcerative colitis in the tofacitinib OCTAVE UC clinical program who underwent colectomy had prior tumor necrosis factor inhibitor failure and most had additional risk factors, according to analysis.

News
August 09, 2023
1 min read
Save

‘Lipid paradox’ may obscure cardiovascular risk in patients with inflammatory disease

‘Lipid paradox’ may obscure cardiovascular risk in patients with inflammatory disease

AUSTIN, Texas — Providers should carefully consider the “lipid paradox” when monitoring cardiovascular risks in patients with rheumatic inflammatory diseases, noted a presenter at the 2023 Rheumatology Nurses Society annual conference.

News
July 26, 2023
1 min read
Save

First patient dosed in global phase 3 trial of Rinvoq for hidradenitis suppurativa

First patient dosed in global phase 3 trial of Rinvoq for hidradenitis suppurativa

Researchers have dosed the first patient in Step-Up HS, a phase 3 study evaluating Rinvoq for moderate to severe hidradenitis suppurativa in adults and adolescents, AbbVie announced in a press release.

News
July 13, 2023
2 min read
Save

Brepocitinib superior to placebo in reducing psoriatic arthritis signs, symptoms

Brepocitinib superior to placebo in reducing psoriatic arthritis signs, symptoms

Brepocitinib, in doses of either 30 mg or 60 mg, is superior to placebo in reducing signs and symptoms of psoriatic arthritis and is “generally well tolerated” through 52 weeks, according to data published in Arthritis & Rheumatology.

News
July 11, 2023
6 min watch
Save

VIDEO: Praise for oral, topical JAK inhibitors for atopic dermatitis

VIDEO: Praise for oral, topical JAK inhibitors for atopic dermatitis

In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including the use of oral and topical JAK inhibitors to treat atopic dermatitis.

News
July 11, 2023
4 min watch
Save

VIDEO: Highlights in psoriasis from Maui Derm NP+PA

VIDEO: Highlights in psoriasis from Maui Derm NP+PA

In this video, George Martin, MD, discusses highlights in the treatment of psoriasis

News
July 04, 2023
4 min watch
Save

VIDEO: Interesting developments in the psoriatic arthritis pipeline

VIDEO: Interesting developments in the psoriatic arthritis pipeline

M. Elaine Husni, MD, MPH, spoke with Healio about treatment and management options in psoriatic arthritis, including lifestyle changes. “We now have really embraced the concept of wellness strategies,” said Husni, vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center and staff physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic, and assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

News
July 03, 2023
3 min watch
Save

VIDEO: Role of JAK inhibitors in RA treatment

VIDEO: Role of JAK inhibitors in RA treatment

In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discusses the role of JAK inhibitors in rheumatoid arthritis treatment, and growing understanding of their effects.

News
June 30, 2023
1 min read
Save

Eosinophilic cellulitis may benefit from treatment targeting Janus kinase

Eosinophilic cellulitis may benefit from treatment targeting Janus kinase

Based on the pathogenesis of eosinophilic cellulitis, treatment targeting Janus kinase 1 and 2 should be developed to treat this disease, according to a study.

Clinical Guidance
Ankylosing Spondylitis
Assessment and Treatment

Janus Kinase (JAK) Inhibitors

Muhammad Asim Kahn, MD, FRCP, MACP; Nurullah Akkoç, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

View more